- Home
- ONEG vs FATE Comparison
ONEG vs FATE Comparison
Compare ONEG & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONEG | FATE |
|---|---|---|
| Founded | 2021 | 2007 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.2M | 131.5M |
| IPO Year | 2024 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ONEG | FATE |
|---|---|---|
| Price | $1.21 | $1.08 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.92 |
| AVG Volume (30 Days) | 564.2K | ★ 1.3M |
| Earning Date | 08-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $53,205,000.00 | $7,137,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $15.75 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.00 | $0.66 |
| 52 Week High | $13.50 | $2.93 |
Technical Indicators
Market Signals| Indicator | ONEG | FATE |
|---|---|---|
| Relative Strength Index (RSI) | 17.35 | 46.64 |
| Support Level | $1.07 | $0.99 |
| Resistance Level | $1.95 | $1.16 |
| Average True Range (ATR) | 0.31 | 0.08 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 12.98 | 61.54 |
Price Performance
Historical ComparisonAbout ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.